All terms in GO
| Label | Id | Description |
|---|---|---|
| negative regulation of non-canonical Wnt signaling pathway | GO_2000051 |
Any process that stops, prevents, or reduces the frequency, rate or extent of non-canonical Wnt signaling pathway.
|
| regulation of planar cell polarity pathway involved in axis elongation | GO_2000040 |
Any process that modulates the frequency, rate or extent of planar cell polarity pathway involved in axis elongation.
|
| negative regulation of double-strand break repair via homologous recombination | GO_2000042 |
Any process that stops, prevents, or reduces the frequency, rate or extent of double-strand break repair via homologous recombination.
|
| negative regulation of DNA recombination | GO_0045910 |
Any process that stops, prevents, or reduces the frequency, rate or extent of DNA recombination.
|
| regulation of cell-cell adhesion mediated by cadherin | GO_2000047 |
Any process that modulates the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
|
| negative regulation of cell-cell adhesion mediated by cadherin | GO_2000048 |
Any process that stops, prevents, or reduces the frequency, rate or extent of cell-cell adhesion mediated by cadherin.
|
| regulation of G1/S transition of mitotic cell cycle | GO_2000045 |
Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the mitotic cell cycle.
|
| regulation of cell cycle G1/S phase transition | GO_1902806 |
Any signalling pathway that modulates the activity of a cell cycle cyclin-dependent protein kinase to modulate the switch from G1 phase to S phase of the cell cycle.
|
| obsolete regulation of G2 phase of mitotic cell cycle | GO_2000046 |
OBSOLETE. Any process that modulates the frequency, rate or extent of G2 phase of mitotic cell cycle.
|
| response to 5-fluoro-2'-deoxyuridine | GO_0097330 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 5-fluoro-2'-deoxyuridine stimulus. 5-fluoro-2'-deoxyuridine is a pyrimidine 2'-deoxyribonucleoside compound having 5-fluorouracil as the nucleobase; it is used to treat hepatic metastases of gastrointestinal adenocarcinomas and for palliation in malignant neoplasms of the liver and gastrointestinal tract.
|
| response to cytarabine | GO_0097331 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a cytarabine stimulus.
|
| response to glycoside | GO_1903416 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a glycoside stimulus.
|
| response to antipsychotic drug | GO_0097332 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an antipsychotic drug stimulus. Antipsychotic drugs are agents that control agitated psychotic behaviour, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect.
|
| response to olanzapine | GO_0097333 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an olanzapine stimulus.
|
| response to perphenazine | GO_0097334 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a perphenazine stimulus. Perphenazine is a phenothiazine derivative having a chloro substituent at the 2-position and a 3-[4-(2-hydroxyethyl)piperazin-1-yl]propyl group at the N-10 position.
|
| response to quetiapine | GO_0097335 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a quetiapine stimulus.
|
| response to risperidone | GO_0097336 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a risperidone stimulus.
|
| response to ziprasidone | GO_0097337 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a ziprasidone stimulus. Ziprasidone is a piperazine compound having 1,2-benzothiazol-3-yl- and 2-(6-chloro-1,3-dihydro-2-oxindol-5-yl)ethyl substituents attached to the nitrogen atoms.
|
| response to clozapine | GO_0097338 |
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clozapine stimulus.
|
| glycolate transmembrane transport | GO_0097339 |
The process in which glycolate is transported across a membrane. Glycolate is the anion of hydroxyethanoic acid (glycolic acid).
|